Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This synthetic peptide demonstrates superior activity compared to single-receptor agonists in preclinical studies.
The molecular structure of tirzepatide features PEG modification on the lysine side chain, enhancing water solubility while maintaining biological activity. Research indicates this dual agonist mechanism produces more significant effects on glucose regulation and weight management than selective GLP-1 receptor agonists alone.
Clinical research has shown tirzepatide's potential in metabolic studies, with phase 3 trials demonstrating significant results in weight management applications. The compound has received regulatory designations to accelerate its development for metabolic research purposes.
Our pharmaceutical grade tirzepatide is produced under strict quality controls, ensuring 99.9% purity for research applications. The white powder is packaged in sterile vials to maintain stability and purity throughout storage and handling.
For researchers looking to buy tirzepatide, we offer flexible quantities from small research samples to bulk orders. Each batch undergoes comprehensive analytical testing including HPLC and mass spectrometry to verify identity and purity.
Proper storage is essential for maintaining tirzepatide stability. The peptide should be kept in a cool, dry environment protected from light and moisture. Avoid repeated freeze-thaw cycles and prolonged exposure to solution phase when possible.
This product is intended for research purposes only. Not for human consumption or diagnostic use. Researchers should handle all peptides using appropriate laboratory safety protocols.
